Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CRABP1 encodes a specific binding protein for a vitamin A family member and is thought to play an important role in retinoic acid-mediated differentiation and proliferation processes. Additionally we are shipping Cellular Retinoic Acid Binding Protein 1 Proteins (20) and many more products for this protein.
Showing 10 out of 73 products:
Cat (Feline) Monoclonal CRABP1 Primary Antibody for ELISA, FACS - ABIN152698
Kelley, Turner, Reh: Retinoic acid promotes differentiation of photoreceptors in vitro. in Development (Cambridge, England) 1994
Show all 5 references for ABIN152698
Human Monoclonal CRABP1 Primary Antibody for EIA, IHC (p) - ABIN400870
Nezzar, Chiambaretta, Marceau, Blanchon, Faye, Dechelotte, Rigal, Sapin: Molecular and metabolic retinoid pathways in the human ocular surface. in Molecular vision 2007
Human Polyclonal CRABP1 Primary Antibody for IHC, IHC (p) - ABIN4300354
Kainov, Favorskaya, Delektorskaya, Chemeris, Komelkov, Zhuravskaya, Trukhanova, Zueva, Tavitian, Dyakova, Zborovskaya, Tchevkina: CRABP1 provides high malignancy of transformed mesenchymal cells and contributes to the pathogenesis of mesenchymal and neuroendocrine tumors. in Cell cycle (Georgetown, Tex.) 2014
Chromosome mapping of CRABP1 (show RBP1 Antibodies) AND CRABP2 (show CRABP2 Antibodies) in swine.
p75NTR (show NGFR Antibodies) and CRABP1 modulate the effect of fenretinide on neuroblastoma (show ARHGEF16 Antibodies) cells
miR (show MLXIP Antibodies)-93/miR (show MLXIP Antibodies)-106b/miR (show MLXIP Antibodies)-375-CIC (show CIC Antibodies)-CRABP1 is a novel key regulatory axis in prostate cancer progression
CRABP1 expression is maintained in ER- and triple-negative breast tumors, and that elevated levels of CRABP1 is a significant indicator of high tumor grade, Ki67 (show MKI67 Antibodies) immunoreactivity, and poor prognosis.
the first evidence of pro-tumorigenic and pro-metastatic activity of CRABP1 in mesenchymal and neuroendocrine tumors.
we demonstrated significant changes in CRABP1 and CRABP2 (show CRABP2 Antibodies) expression in non-small cell lung cancer samples
Factors involved in the retinoid pathway, in particular upregulation of CRBP (show RBP1 Antibodies), CRABP1 and CRABP2 (show CRABP2 Antibodies), also showed differential expression in tumors with different histological subtypes
Results describe the mRNA expression of CRABP1, RERG (show RERG Antibodies), and GRP (show LSM4 Antibodies) in pituitary adenomas.
reduced expression of CRABP1 has a potential as a prognostic marker for serous adenocarcinoma which is the most frequent histological ovarian tumor type and also for clear cell carcinoma that often exhibits chemo-resistance.
Loss of cellular retinoic acid binding protein 1 function due to hypermethylation of its promoter leads to pathogenesis of papillary thyroid carcinoma
CSF of Moyamoya Disease [MMD] patients reveals high CRABP-I expression suggesting that the elevation of CRABP-I in CSF may be a candidate for pathogenesis of MMD
This study reveals a physiological relevance of the non-genomic action of atRA, mediated by Crabp1, in modulating cell cycle progression and apoptosis induction
Only a small fraction of CRABP1 populates this functionally important but vulnerable conformation of CRABP1, enabling efficient ligand binding.
CRABPI binds to all-trans retinoic acid in the cytoplasm, resulting in rapid ERK1/2 (show MAPK1/3 Antibodies) activation that is independent of membrane signal and nuclear RA receptors.
These data suggest that CRABPI functions to regulate the intracellular concentrations of retinoic acid and to maintain high levels of oxidized retinoic acid metabolites such as 4-oxoretinoic acid within cells.
The expression of CRABP I in the embryonic cerebellum coincides with earliest cerebellar differentiation; its involvement in a complex network of regulatory genes expressed in the mes (show PTCH1 Antibodies)/methencephalon is discussed in this review.
This study presents the first evidence that over-expressed receptor interacting protein 140 (show NRIP1 Antibodies) acts as a thyroid hormone (show PTH Antibodies) (T3)-dependent negative co-regulator for T3 induction of the endogenous cellular retinoic acid binding I protein gene in P19 (show CDKN2D Antibodies) cells.
proline isomerization may not be responsible for the slowest folding phase of CRABP I so the loss of a slow refolding phase upon mutation may not be diagnostic for proline isomerization effects on protein folding
Increases in CRABPI and II transcripts in the absence of leukemia inhibitory factor (show LIF Antibodies) may regulate aspects of embryonic stem cell differentiation in response to retinol.
This gene encodes a specific binding protein for a vitamin A family member and is thought to play an important role in retinoic acid-mediated differentiation and proliferation processes. It is structurally similar to the cellular retinol-binding proteins, but binds only retinoic acid at specific sites within the nucleus, which may contribute to vitamin A-directed differentiation in epithelial tissue.
cellular retinoic acid binding protein 1
, cellular retinol binding protein 1
, cellular retinoic acid-binding protein 1
, retinol-binding protein 5-like
, retinol binding protein 5, cellular
, retinol-binding protein 5
, cellular retinoic acid binding protein I (CRABP-I) homologue
, cellular retinoic acid-binding protein I
, cellular retinoic acid binding protein I
, cellular retinol-binding protein III
, retinol-binding protein III, cellular